Pfizer says trials on lymphoma drug ‘positive,’ extends life of patients
HQ Team March 12, 2024: Pfizer Inc., announced that a late-stage study on its Adcetris drug, for treating the most common lymphoma, yielded.
Drugs
Health
Pharma